Predictors of Early Failure after Fecal Microbiota Transplantation for the Therapy of Clostridium Difficile Infection: A Multicenter Study

American Journal of Gastroenterology

Volumn 111, Issue 7, 2016, Pages 1024-1031

  Fischer, Monika ^a   Kao, Dina ^b   Mehta, Shama R ^b   Martin, Tracey ^c   Dimitry, Joseph ^b   Keshteli, Ammar H ^b   Cook, Gwendolyn K ^a   Phelps, Emmalee ^a   Sipe, Brian W ^a   Xu, Huiping ^a   Kelly, Colleen R ^c  

^a INDIANA UNIVERSITY   (United States)

^b UNIVERSITY OF ALBERTA   (Canada)

^c BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VANCOMYCIN;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; CLOSTRIDIUM DIFFICILE INFECTION; COHORT ANALYSIS; DIARRHEA; DRUG TREATMENT FAILURE; FECAL MICROBIOTA TRANSPLANTATION; FECES ANALYSIS; FEMALE; HIGH RISK PATIENT; HOSPITALIZATION; HUMAN; INFLAMMATORY BOWEL DISEASE; LOW RISK PATIENT; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PATIENT CODING; PEPTOCLOSTRIDIUM DIFFICILE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECURRENT DISEASE; RETROSPECTIVE STUDY; RISK FACTOR; TERTIARY CARE CENTER; ADVERSE EFFECTS; AGED; CLINICAL TRIAL; ENTEROCOLITIS, PSEUDOMEMBRANOUS; ISOLATION AND PURIFICATION; MICROBIOLOGY; MIDDLE AGED; PATHOGENICITY; PATHOPHYSIOLOGY; PATIENT CARE PLANNING; PROCEDURES; PROGNOSIS; SEVERITY OF ILLNESS INDEX; STATISTICAL MODEL; TREATMENT FAILURE; UNITED STATES;

ADULT; AGED; CLOSTRIDIUM DIFFICILE; DIARRHEA; ENTEROCOLITIS, PSEUDOMEMBRANOUS; FECAL MICROBIOTA TRANSPLANTATION; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; PATIENT CARE PLANNING; PROGNOSIS; RECURRENCE; RETROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TREATMENT FAILURE; UNITED STATES;

EID: 84976543188     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2016.180     Document Type: Article

References (23)

1. McFarland LV, Elmer GW, Surawicz CM. Breaking the cycle: treatment strategies for 163 cases of recurrent Clostridium difficile disease. The Am J Gastroenterol 2002; 97: 1769-75.
2. Mattila E, Uusitalo-Seppala R, Wuorela M et al. Fecal transplantation, through colonoscopy, is effective therapy for recurrent Clostridium difficile infection. Gastroenterology 2012; 142: 490-6.
3. Bakken JS, Borody T, Brandt LJ et al. Treating Clostridium difficile infection with fecal microbiota transplantation. Clin Gastroenterol Hepatol 2011; 9: 1044-9.
4. Borody TJ, Paramsothy S, Agrawal G. Fecal microbiota transplantation: indications, methods, evidence, and future directions. Curr Gastroenterol Rep 2013; 15: 337.
5. Kelly CR BL, Abd M, Alani M et al. A multicenter, randomized, placebocontrolled, double-blind study to evaluate the efficacy and safety of fecal microbiota transplantation in patients with recurrent Clostridium difficile infection. American College of Gastroenterology Meeting, Honolulu, HI, 2015
6. Cammarota G, Masucci L, Ianiro G et al. Randomised clinical trial: faecal microbiota transplantation by colonoscopy vs. vancomycin for the treatment of recurrent Clostridium difficile infection. Aliment Pharmacol Ther 2015; 41: 835-43.
7. van Nood E, Dijkgraaf MG, Keller JJ. Duodenal infusion of feces for recurrent Clostridium difficile. N Engl J Med 2013; 368: 2145.
8. Kassam Z, Lee CH, Yuan Y et al. Navigating long-term safety in fecal microbiota transplantation. Am J Gastroenterol 2013; 108: 1538.
9. Gough E, Shaikh H, Manges AR. Systematic review of intestinal microbiota transplantation (fecal bacteriotherapy) for recurrent Clostridium difficile infection. Clin Infect Dis 2011; 53: 994-1002.
10. Cammarota G, Ianiro G, Bibbo S et al. Fecal microbiota transplantation: a new old kid on the block for the management of gut microbiota-related disease. J Clin Gastroenterol 2014; 48 ( Suppl 1 ): S80-4.
11. Kassam Z, Lee CH, Yuan Y et al. Fecal microbiota transplantation for Clostridium difficile infection: systematic review and meta-analysis. Am J Gastroenterol 2013; 108: 500-8.
12. Hamilton MJ, Weingarden AR, Sadowsky MJ et al. Standardized frozen preparation for transplantation of fecal microbiota for recurrent Clostridium difficile infection. Am J Gastroenterol 2012; 107: 761-7.
13. Lee CH, Steiner T, Petrof EO et al. Frozen vs. fresh fecal microbiota transplantation and clinical resolution of diarrhea in patients with recurrent Clostridium difficile infection: a randomized clinical trial. JAMA 2016; 315: 142-9.
14. Lee CH, Belanger JE, Kassam Z et al. The outcome and long-term follow-up of 94 patients with recurrent and refractory Clostridium difficile infection using single to multiple fecal microbiota transplantation via retention enema. Eur J Clin Microbiol Infect Dis 2014; 33: 1425-8.
15. Fischer M, Sipe BW, Rogers NA et al. Faecal microbiota transplantation plus selected use of vancomycin for severe-complicated Clostridium difficile infection: description of a protocol with high success rate. Aliment Pharmacol Ther 2015; 42: 470-6.
16. Kelly CR, Ihunnah C, Fischer M et al. Fecal microbiota transplant for treatment of Clostridium difficile infection in immunocompromised patients. Am J Gastroenterol 2014; 109: 1065-71.
17. Surawicz CM, Brandt LJ, Binion DG et al. Guidelines for diagnosis, treatment, and prevention of Clostridium difficile infections. Am J Gastroenterol 2013; 108: 478-98; quiz 99.
18. Weingarden AR, Hamilton MJ, Sadowsky MJ et al. Resolution of severe Clostridium difficile infection following sequential fecal microbiota transplantation. J Clin Gastroenterol 2013; 47: 735-7.
19. Baggs J, Yousey-Hindes K, Ashley ED et al. Identification of population at risk for future Clostridium difficile infection following hospital discharge to be targeted for vaccine trials. Vaccine 2015; 33: 6241-9.
20. Ananthakrishnan AN, McGinley EL, Saeian K et al. Temporal trends in disease outcomes related to Clostridium difficile infection in patients with inflammatory bowel disease. Inflamm Bowel Dis 2011; 17: 976-83.
21. Sanchez TH, Brooks JT, Sullivan PS et al. Bacterial diarrhea in persons with HIV infection, United States, 1992-2002. Clin Infect Dis 2005; 41: 1621-7.
22. Gorschluter M, Glasmacher A, Hahn C et al. Clostridium difficile infection in patients with neutropenia. Clin Infect Dis 2001; 33: 786-91.
23. Khoruts A, Rank KM, Newman KM et al. Inflammatory bowel disease affects the outcome of fecal microbiota transplantation for recurrent Clostridium difficile infection. Clin Gastroenterol Hepatol 2016 (in press).